ArticlePharmaceutics2026

Reductant-Responsive Squalene Dual-Prodrug Nanoparticles Co-Delivering Doxorubicin and Exatecan for Synergistic Breast Tumor Therapy.

Li Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.